Recent Patents on CNS Drug Discovery (Discontinued)


Vincenzo Di Marzo
Istituto di Chimica Biomolecolare (I.C.B.)
Consiglio Nazionale delle Ricerche (C.N.R.)
Via Campi Flegrei 34
Pozzuoli, Napoli 80078

Personal Subscription

Rho-ROCK Inhibitors for the Treatment of CNS Injury

Volume:2   Issue: 3
Pp: 173-179
Takekazu Kubo and Toshihide Yamashita
DOI: 10.2174/157488907782411738

Therapeutic Treatment of Alzheimers Disease Using Metal Complexing Agents

Volume:2   Issue: 3
Pp: 180-187
Katherine A. Price, Peter J. Crouch and Anthony R. White
DOI: 10.2174/157488907782411774

BACE Inhibitors as Potential Therapeutics for Alzheimers disease

Volume:2   Issue: 3
Pp: 188-199
Genevieve Evin and Vijaya B. Kenche
DOI: 10.2174/157488907782411783

Potassium Channel Blockers and Openers as CNS Neurologic Therapeutic Agents

Volume:2   Issue: 3
Pp: 200-228
Susan I.V. Judge, Paul J. Smith, Peggy E. Stewart and Christopher T. Bever Jr.
DOI: 10.2174/157488907782411765

Translating Genetic Findings into Therapy in Parkinson Disease

Volume:2   Issue: 3
Pp: 229-237
Sagrario M. Palomo and Adriano Jimenez-Escrig
DOI: 10.2174/157488907782411747

Therapeutic Approach of Histamine H3 Receptors in Obesity

Volume:2   Issue: 3
Pp: 238-240
Takayuki Masaki and Hironobu Yoshimatsu
DOI: 10.2174/157488907782411792

In Search of Novel and Therapeutically Significant Melatoninergic Ligands

Volume:2   Issue: 3
Pp: 241-245
Sejal M. Mody, Yueqing Hu, Maurice K.C. Ho and Yung H. Wong
DOI: 10.2174/157488907782411756

Patent Selections promotion: free to download

Volume:2   Issue: 3
Pp: 246-249
Bentham Science Publishers
DOI: 10.2174/157488907782411729